We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+14.52%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$247M
AUM Growth
+$26.9M
Cap. Flow
+$1.99M
Cap. Flow %
0.81%
Top 10 Hldgs %
28.64%
Holding
82
New
13
Increased
21
Reduced
29
Closed
19

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$5.2M
2
VTRS icon
Viatris
VTRS
+$4.79M
3
GILD icon
Gilead Sciences
GILD
+$4.11M
4
UNH icon
UnitedHealth
UNH
+$4.05M
5
ESRX
Express Scripts Holding Company
ESRX
+$3.65M

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$5.03M
2
EVHC
Envision Healthcare Holdings Inc
EVHC
+$4.33M
3
WBA
Walgreens Boots Alliance
WBA
+$4.15M
4
COR icon
Cencora
COR
+$3.44M
5
TMH
Team Health Holdings Inc
TMH
+$2.9M

Sector Composition

Rank Sector Weight
1 Healthcare 89.54%
2 Industrials 0.78%
3 Energy 0.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHPG
51
DELISTED
Shire pic
SHPG
$2.08M 0.84%
+9,800
New +$2.08M
VWR
52
DELISTED
VWR Corporation
VWR
$1.93M 0.78%
+74,400
New +$1.77M
NUVA
53
DELISTED
NuVasive, Inc.
NUVA
$1.92M 0.78%
+40,700
New +$1.7M
LHCG
54
DELISTED
LHC Group LLC
LHCG
$1.85M 0.75%
59,500
+9,500
+19% +$240K
CCRN
55
DELISTED
Cross Country Healthcare
CCRN
$1.85M 0.75%
148,300
-101,700
-41% -$1.04M
PODD icon
56
Insulet
PODD
$10B
$1.81M 0.74%
39,400
-600
-2% -$25.7K
NXTM
57
DELISTED
NxStage Medical Inc.
NXTM
$1.79M 0.72%
99,700
-300
-0.3% -$4.83K
VRTX icon
58
Vertex Pharmaceuticals
VRTX
$134B
$1.77M 0.72%
14,900
-15,100
-50% -$1.7M
ACH
59
Accendra Health
ACH
$96.5M
$1.75M 0.71%
49,900
-50,100
-50% -$1.69M
GMED icon
60
Globus Medical
GMED
$11.4B
$1.71M 0.69%
+71,900
New +$1.59M
STE icon
61
Steris
STE
$23.2B
$1.65M 0.67%
+25,367
New +$1.57M
IPXL
62
DELISTED
Impax Laboratories, Inc.
IPXL
$1.57M 0.64%
+49,600
New +$1.45M
ELV icon
63
Elevance Health
ELV
$84.7B
$1.08M 0.44%
8,560
-11,440
-57% -$1.41M
A icon
64
Agilent Technologies
A
$42.2B
– –
-55,920
Closed -$2.28M
ABBV icon
65
AbbVie
ABBV
$442B
– –
-40,000
Closed -$2.31M
BDX icon
66
CALL
Becton Dickinson
BDX
$49.4B
– –
-25,625
Closed -$26K
CI icon
67
PUT
Cigna
CI
$72.4B
– –
-25,000
Closed -$67K
DGX icon
68
CALL
Quest Diagnostics
DGX
$26.2B
– –
-50,000
Closed -$33K
ICLR icon
69
Icon
ICLR
$12.8B
– –
-45,000
Closed -$2.58M
LH icon
70
Labcorp
LH
$26.1B
– –
-57,502
Closed -$5.03M
RMD icon
71
ResMed
RMD
$32.6B
– –
-45,000
Closed -$2.22M
SPY icon
72
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$807B
– –
-150,000
Closed -$504K
SYK icon
73
CALL
Stryker
SYK
$134B
– –
-50,000
Closed -$62K
UNH icon
74
PUT
UnitedHealth
UNH
$365B
– –
-50,000
Closed -$64K
WBA
75
DELISTED
Walgreens Boots Alliance
WBA
– –
-70,000
Closed -$4.15M
1 2
3
4

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q4 2014 Portfolio in Review

As of Q4 2014, Sivik Global Healthcare held 82 positions worth $247M, up 12% from $220M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Sivik Global Healthcare's Q4 2014 filing shows 13 new, 21 increased, 29 reduced and 19 closed positions. Its largest new stake was Becton Dickinson: 40,693 shares worth $5.53M. The largest sale was Labcorp, an estimated $5.03M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 89% a quarter earlier, followed by Industrials and Energy.

  • Sivik Global Healthcare's largest Q4 2014 buy was Becton Dickinson: 40,693 shares worth $5.53M.
  • Sivik Global Healthcare added most to Celgene Corp in Q4 2014, an estimated $3.3M increase.
  • Sivik Global Healthcare's biggest Q4 2014 reduction was Cencora, cutting an estimated $3.44M.
  • Sivik Global Healthcare fully exited Labcorp in Q4 2014, selling an estimated $5.03M.
  • Sivik Global Healthcare's ten largest holdings make up 29% of its $247M portfolio in Q4 2014.
  • Sivik Global Healthcare opened 13 new positions and closed 19 in Q4 2014.
  • Sivik Global Healthcare's portfolio value rose 12% quarter-over-quarter to $247M.

Based on Sivik Global Healthcare's 13F filing for Q4 2014, filed 7 Jan 2015.